[#item_full_content] The Drug Enforcement Administration (DEA) is reiterating that it doesn’t believe a recently published federal watchdog agency report that found “gaps” in the government’s process for evaluating controlled substances undermines the Trump administration’s proposal to reschedule marijuana. But anti-rescheduling parties that are participating in a hearing on the reform say that procedural shortcomings have irreparably  Read More